NOTICE: The Taxi stand/drop-off point at the Medical Centre will be closed on November/December 24. Alternative drop-off locations are available at the Medical Centre (after the carpark gantry) or at the Main Lobby of Mount Elizabeth Hospital.

Dr. Lim Hong Liang

Medical Oncology (Cancer)

Credentials MBBS (Singapore) MMed (Internal Medicine) FAMS (Medical Oncology)
Language English,Mandarin Chinese,Hokkien Dialect,Cantonese Dialect
Background

Dr Lim Hong Liang is a senior medical oncologist with more than 25 years of experience. In addition to general medical oncology, he has a special interest in lung cancers, and head and neck cancers.

Dr Lim graduated from the National University of Singapore (MBBS) in 1986. He received his training in internal medicine and medical oncology at the National University Hospital Singapore (NUH). In 1992, he received a Japan JICA scholaship for further training in the Department of Thoracic Oncology at the Tokyo National Cancer Cantre Japan. Dr Lim was also trained in high dose chemotherapy and bone marrow transplant at the St Vincent’s Hospital in Sydney Australia in 1995 under a scholarship from the Ministry of Health Singapore.

Prior to joining the Parkway Cancer Centre, Dr Lim headed the Thoracic Oncology Service, Head and Neck Service and Bone Marrow Transplant Program at the National University Hospital. He was also the lead medical oncologist at the Tan Tock Seng Hospital Lung Tumour Clinic from 1996 to 2005. Before leaving for private practice in 2005, Dr Lim was the Chief of the Department of Haematology and Oncology and the Associate Chairman of the Medical Board of the National University Hospital.

Dr Lim is a Fellow of the Academy of Medicine and a member of American Society of Clinical Oncology and International Association for the Study of Lung Cancer. He is also a member of the Singapore Cancer Registry Advosry Committee. Past positions include President of the Singapore Society of Oncology, member of the Ministry of Health Advisory Committee for Cancer Care and Medical Oncology Training Committee.